Life-threatening hypercalcemia in patients with rhabdomyolysis-induced oliguric acute renal failure

J Nephrol. 2011 Jan-Feb;24(1):128-31. doi: 10.5301/jn.2010.5794.

Abstract

Background: In a third of patients presenting with rhabdomyolysis-induced acute renal failure (ARF), a biphasic plasma calcium profile may occur.

Methods: We report a case of rhabdomyolysis-induced ARF presenting hypocalcemia during oliguria, followed by a severe hypercalcemia in the polyuric phase. A hypocalcemia-induced acute increase of plasma parathyroid hormone in the early stage of ARF was followed by a down-regulation of parathyroid hormone, 1,25(OH)2 vitamin D and 25(OH) vitamin D during the renal function recovery, associated with an acute hypercalcemia. The plasma calcium increase induced in our patient severe neurological disturbances, life-threatening short QT interval and Brugada-like syndrome at risk of malignant arrhythmias. This complication was treated by hemodialysis and pamidronic acid infusion.

Results: This case confirms that the pathogenesis of the biphasic calcium profile may be related to the massive calcium uptake in the ischemic muscle cells during oliguria, followed by a muscle calcium release later in the polyuric stage of ARF. Therefore, the behavior of calciotropic hormones may be the consequence rather than the cause of plasma calcium changes.

Conclusions: We would like to emphasize the danger of sudden death that may occur in the recovery phase of rhabdomyolysis-induced ARF when the physician might be wrongly convinced that the major risks have disappeared.

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury / blood
  • Acute Kidney Injury / etiology*
  • Acute Kidney Injury / therapy
  • Arrhythmias, Cardiac / etiology
  • Biomarkers / blood
  • Calcium / blood
  • Diphosphonates / administration & dosage
  • Humans
  • Hypercalcemia / blood
  • Hypercalcemia / etiology*
  • Hypercalcemia / therapy
  • Male
  • Middle Aged
  • Muscle, Skeletal / metabolism
  • Oliguria / blood
  • Oliguria / etiology*
  • Oliguria / therapy
  • Pamidronate
  • Parathyroid Hormone / blood
  • Renal Dialysis
  • Rhabdomyolysis / blood
  • Rhabdomyolysis / complications*
  • Time Factors
  • Treatment Outcome
  • Vitamin D / analogs & derivatives
  • Vitamin D / blood

Substances

  • Biomarkers
  • Diphosphonates
  • PTH protein, human
  • Parathyroid Hormone
  • Vitamin D
  • 1,25-dihydroxyvitamin D
  • 25-hydroxyvitamin D
  • Pamidronate
  • Calcium